Overview:

• Dr. Paicius founded Newport Beach Headache and Pain in 1996. He has been named one of “Orange County’s Best Doctors”. Specializing in interventional pain management, he is recognized internationally for his work in spinal cord stimulation. Having had academic positions at UCLA and UC Irvine in Anesthesiology and Pain Management, he has built a multi-disciplinary team in Newport Beach to address the varied needs of pain patients.

​

• After graduating medical school from The University of Arizona, he completed his residency and internship at Harbor-UCLA Medical Center. Dr. Paicius is board certified by the American Board of Anesthesiology, the American Board of Pain Medicine, and earned extended qualifications by the ABA. He has taught hundreds of physicians advanced techniques in interventional pain management. Using a multi-disciplinary approach, Dr. Paicius customizes care depending on the patient’s needs and desires.

​

Stem Cell Research:

• As a national center for research, Dr Paicius has been involved in studies for abdominal pain, for headache, for failed back surgery as well as the innovative area of regenerative medicine. Recently Dr. Paicius completed a study for back pain with introduction of stem cells into the intervertebral disc with amazing success.

​

• As we continue to be a national center for research, newer treatments for pain become available on a monthly basis. Below are some of the studies Dr Paicius has been involved in for the last several years.

​

Research Cases:

A Prospective Clinical Trial to Assess the Feasibility of the SENZA Spinal Cord Stimulation (SCS) System in the Treatment of Chronic Abdominal Pain

​

Purpose: The purpose of this study is to find out whether electrical stimulation of the spinal cord using SENZA is safe and useful in the treatment of chronic (long-term) pain of the abdomen.

 

Enrollment Status: Not enrolling, active patients.

​

A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Alone or Combined with Hyaluronic Acid (HA) in Subjects with Chronic Low Back Pain

​

Purpose: The purpose of this research study is to evaluate an investigational product called, rexlemestrocel-L. This study is designed to determine whether rexlemestrocel-L, used alone, or in combination with a carrier material (hyaluronic acid), is safe and effective in treating low back pain by repairing damaged spinal discs.

 

Enrollment Status: Not enrolling, active patients.

​

A Post Market Registry for Evaluation of the Superion Spacer

​

Purpose: This registry is being conducted to collect additional data about the performance of the Superion Indirect Decompression System which is manufactured by Vertiflex. The device was approved by the FDA for sale in the U.S. in May 20, 2015.

 

Enrollment Status: Enrolling, active patients.

​